In this issue:
Efficacy and safety of cemdisiran
Indirect comparison of nipocalimab versus efgartigimod
Safety and efficacy of vemircopan
Treatment discontinuation in patients with myelin oligodendrocyte
Neuromuscular signs and symptoms, muscle biopsy, and pathology of anti-IgLON5 disease
Long-term ravulizumab efficacy
Health-related quality of life outcomes with nipocalimab
Predictive factors for non-response to first use of polyvalent IVIG
Video-oculographic saccadic fatigability
Treatment preferences for subcutaneous immunoglobulin
Please login below to download this issue (PDF)